Items without sitelinks

From determinar.ia.br - Determine suas informações

Showing below up to 50 results in range #10,201 to #10,250.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Unintentional exposure to or harmful effects of peripheral vasodilators (Q102609)
  2. Unintentional exposure to or harmful effects of angiotensin-converting-enzyme inhibitors (Q102608)
  3. Unintentional exposure to or harmful effects of antivaricose drugs, including sclerosing agents (Q102607)
  4. Unintentional exposure to or harmful effects of other coronary vasodilators (Q102606)
  5. Unintentional exposure to or harmful effects of antiviral drugs (Q102605)
  6. Unintentional exposure to or harmful effects of sulfonamides (Q102604)
  7. Unintentional exposure to or harmful effects of nitroglycerin, nitroglycerol, medicinal (Q102603)
  8. Unintentional exposure to or harmful effects of other hormone antagonists (Q102602)
  9. Unintentional exposure to or harmful effects of unspecified hormone antagonists (Q102601)
  10. Unintentional exposure to or harmful effects of camphor (Q102600)
  11. Unintentional exposure to or harmful effects of antithyroid drugs (Q102599)
  12. Unintentional exposure to or harmful effects of androgens or anabolic congeners (Q102598)
  13. Unintentional exposure to or harmful effects of antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified (Q102597)
  14. Unintentional exposure to or harmful effects of anterior pituitary hormones (Q102596)
  15. Unintentional exposure to or harmful effects of glucocorticoids or synthetic analogues (Q102595)
  16. Unintentional exposure to or harmful effects of unspecified hormones or synthetic substitutes (Q102594)
  17. Unintentional exposure to or harmful effects of other hormones or synthetic substitutes (Q102593)
  18. Unintentional exposure to or harmful effects of other estrogens or progestogens (Q102592)
  19. Unintentional exposure to or harmful effects of insulin or oral hypoglycaemic drugs (Q102591)
  20. Unintentional exposure to or harmful effects of oral contraceptives (Q102590)
  21. Unintentional exposure to or harmful effects of thyroid hormones or substitutes (Q102589)
  22. Unintentional exposure to or harmful effects of other dental drugs, topically applied (Q102588)
  23. Unintentional exposure to or harmful effects of otorhinolaryngological drugs or preparations (Q102587)
  24. Unintentional exposure to or harmful effects of fluoride preparations (Q102586)
  25. Unintentional exposure to or harmful effects of ophthalmological drugs or preparations (Q102585)
  26. Unintentional exposure to or harmful effects of keratolytics, keratoplastics, or other hair treatment drugs or preparations (Q102584)
  27. Unintentional exposure to or harmful effects of iodine, antiseptic (Q102583)
  28. Unintentional exposure to or harmful effects of podophyllin (Q102582)
  29. Unintentional exposure to or harmful effects of emollients, demulcents or protectants (Q102581)
  30. Unintentional exposure to or harmful effects of other local antifungal, anti-infective or anti-inflammatory drugs (Q102580)
  31. Unintentional exposure to or harmful effects of other local astringents or local detergents (Q102579)
  32. Unintentional exposure to or harmful effects of iron or its compounds (Q102578)
  33. Unintentional exposure to or harmful effects of silver nitrate (Q102577)
  34. Unintentional exposure to or harmful effects of methyl salicylate (Q102576)
  35. Unintentional exposure to or harmful effects of antipruritics (Q102575)
  36. Unintentional exposure to or harmful effects of anticoagulant antagonists, vitamin K or other coagulants (Q102574)
  37. Unintentional exposure to or harmful effects of thrombolytic drug (Q102573)
  38. Unintentional exposure to or harmful effects of anticoagulants (Q102572)
  39. Unintentional exposure to or harmful effects of topical corticosteroid preparations (Q102571)
  40. Unintentional exposure to or harmful effects of other primarily systemic agents, not elsewhere classified (Q102570)
  41. Congenital anomaly of organ of Corti (Q102569)
  42. Unintentional exposure to or harmful effects of antithrombotic drugs (Q102568)
  43. Unintentional exposure to or harmful effects of other fibrinolysis-affecting drugs (Q102567)
  44. Unintentional exposure to or harmful effects of acidifying or alkalising agents (Q102566)
  45. Congenital anomaly of membranous labyrinth (Q102565)
  46. Unintentional exposure to or harmful effects of plasma substitutes (Q102564)
  47. Unintentional exposure to or harmful effects of natural blood or blood products (Q102563)
  48. Unintentional exposure to or harmful effects of vitamin B12, folic acid or other anti-megaloblastic-anaemia preparations (Q102562)
  49. Unintentional exposure to or harmful effects of enzymes (Q102561)
  50. Unintentional exposure to or harmful effects of immunosuppressive agents (Q102560)

View ( | ) (20 | 50 | 100 | 250 | 500)

Retrieved from "https://determinar.ia.br/wiki/Special:ItemsWithoutSitelinks"